P. Hoehn et al., OPPOSING EFFECTS OF TGF-BETA(2) ON THE TH1 CELL-DEVELOPMENT OF NAIVE CD4(-CELLS ISOLATED FROM DIFFERENT MOUSE STRAINS() T), The Journal of immunology, 155(8), 1995, pp. 3788-3793
The development of naive dense CD4(+) T cells from different mouse str
ains toward Th1 cells, as monitored by measuring secondary IFN-gamma p
roduction, was affected by TCF-beta(2) in a differential way. Th1 cell
development of naive CD4(+) T cells from strains C57Bl/6, BALB/c, and
NMRI primed by immobilized anti-CD3 mAb was strongly inhibited in the
presence of TGF-beta(2). Even when the Th1 cell-inducer IL-12 was add
ed, the same effect of TGF-beta(2) was observed. In contrast, Th1 deve
lopment was substantially promoted by TCF-beta(2) with T cells from C3
H/He and CPA/J mice. Further analyses using CD4(+) T cells from (C57Bl
/6xCBA/J)F-1 hybrids or DBA/1 mice showed that Th1 development was inh
ibited by TGF-beta(2) if the T cells were activated by anti-CD3 mAb, b
ut it was enhanced upon costimulation with anti-CD28 mAb. Determinatio
n of primary IL-2 production revealed that T cells from (C57Bl/6xCBA/J
)F-1 and DBA/1 mice produced low amounts of IL-2 following stimulation
by anti-CD3 mAb alone and comparatively high amounts after coactivati
on by anti-CD28 mAb. In the presence of TGF-beta(2), the production of
IL-2 was completely suppressed if such T cells were activated solely
by anti-CD3 mAb, but it was only partially inhibited after costimulati
on by anti-CD28 mAb. Furthermore, TCF-beta(2)-promoted Th1 development
of such T cells was strongly inhibited after neutralization of endoge
nously produced IL-2 and completely restored by the addition of human
IL-2. Thus, our results indicate that the TCF-beta(2)-mediated stimula
tion of Th1 cell development requires the presence of relatively high
concentrations of IL-2. Therefore, the opposing effect of TGF-beta(2)
on the Th1 cell development of naive CD4(+) T cells from different mou
se strains appearsto be the result of the variable potency of the resp
ective CD4(+) T cells to produce IL-2 in the presence of TCF-beta(2).